Opioid crisis in the US - Business & addiction (1/2) | DW Documentary

The Opioid Crisis: From Purdue Pharma to Fentanyl – A Detailed Summary

Key Concepts:

• Oxycodone/Oxycontin: Highly addictive opioid pain medication manufactured by Purdue Pharma.
• Sackler Family: Owners of Purdue Pharma, central figures in the marketing and promotion of Oxycontin.
• Pseudo-Addiction: A false diagnosis promoted by Purdue to downplay the addictive potential of Oxycontin.
• McKenzie & Company: Management consulting firm hired by Purdue to maximize profits, including strategies questioned for ethical concerns.
• Fentanyl: A potent synthetic opioid driving the current phase of the opioid crisis.
• Diversion: The illegal channeling of prescription drugs for non-medical use.
• Blockbuster Drug: A pharmaceutical product generating extremely high revenue.

I. The Genesis of the Crisis: Purdue Pharma and Oxycontin (1990s-2000s)

The documentary traces the origins of the opioid crisis not to Mexico, as often portrayed, but to the aggressive marketing of Oxycontin by Purdue Pharma in the United States. The Sackler family, owners of Purdue, are presented as central figures who prioritized profit over patient safety. Despite knowing the addictive potential of opioids, Purdue actively downplayed this risk, claiming Oxycontin was less addictive than other painkillers. This claim was supported by misleading marketing tactics and the promotion of the concept of “pseudo-addiction” – framing addiction as simply a patient’s unmet pain management needs.

Purdue revolutionized pharmaceutical marketing, targeting physicians with aggressive sales tactics and incentives. Sales representatives were trained to avoid language like “oxy” (street name for Oxycodone) in their notes and were rewarded with substantial bonuses tied to prescription volume. The company’s sales force expanded rapidly, particularly in economically depressed areas like Appalachia, which became a focal point for opioid abuse.

A key figure, Carol Panara, a former Purdue sales representative, recounts the unsettling atmosphere within the company and the pressure to promote the drug regardless of ethical concerns.

II. The Role of Regulatory Capture and Internal Corruption

The documentary highlights a critical turning point: the failure of the Department of Justice (DOJ) to prosecute Purdue Pharma in 2006 despite a comprehensive 100-page memo detailing the company’s fraudulent marketing practices and corruption of FDA medical officer Curtis Wright. Wright, responsible for approving Oxycontin, allegedly received assistance from Purdue in drafting favorable reviews and was subsequently hired by the company.

The decision not to pursue criminal charges is attributed to political interference and the influence of Rudy Giuliani, who was representing Purdue at the time. This allowed Purdue to continue its aggressive marketing strategy, leading to a surge in Oxycontin sales and a corresponding increase in addiction and overdose deaths.

III. McKenzie & Company’s Involvement and Profit Maximization

Following the 2007 settlement with the DOJ, Purdue hired McKenzie & Company, a global management consulting firm, to further maximize profits. McKenzie developed strategies to “turbocharge” Oxycontin sales, including exploring the possibility of offering financial incentives to doctors for increased prescriptions, even in cases leading to patient death.

While McKenzie claims to have apologized for its involvement and states it failed to recognize the broader societal context, critics argue that the firm knowingly aided Purdue in perpetuating the opioid crisis for financial gain. The documentary draws parallels between McKenzie’s actions and those of drug cartels, questioning the ethical boundaries of corporate consulting.

IV. The Escalation to Fentanyl and the Current Crisis

As awareness of Oxycontin’s dangers grew and regulations tightened, the opioid crisis evolved. Users began seeking cheaper and more potent alternatives, leading to a surge in heroin and, ultimately, fentanyl use. Fentanyl, a synthetic opioid 50-100 times stronger than morphine, is now the primary driver of overdose deaths in the United States.

The documentary illustrates the devastating impact of fentanyl through personal stories of addiction and loss, including the account of a mother searching for her sister who is struggling with fentanyl addiction. The crisis has spread beyond prescription opioids, impacting communities across the country and leading to a public health emergency.

V. International Implications and Regulatory Differences

The documentary contrasts the US experience with that of France, which implemented stricter regulations on opioid prescriptions, effectively mitigating the epidemic. France’s approach emphasizes careful monitoring and limitations on prescribing practices, highlighting the importance of proactive regulatory measures.

The Sacklers attempted to expand their market globally, but faced resistance in countries like Switzerland, where regulations required psychiatric evaluations for patients prescribed multiple opioids.

VI. Accountability and the Fight for Justice

The documentary follows the efforts of attorneys, like Ma Rahili, to hold the Sackler family and Purdue Pharma accountable for their role in the opioid crisis. Rahili’s investigation uncovered evidence of the Sacklers’ deliberate attempts to conceal their wealth and evade legal repercussions.

The documentary features excerpts from Congressional testimony, where Richard Sackler faced questioning about his family’s actions and financial dealings. The Sacklers’ attempts to downplay their responsibility and deflect blame are met with skepticism and outrage.

VII. Personal Stories of Loss and Recovery

Throughout the documentary, personal narratives provide a poignant and human dimension to the crisis. Dr. Ortenzio, a physician who became addicted to opioids after prescribing them to patients, shares his story of recovery and redemption. Families who have lost loved ones to opioid overdose recount their grief and advocate for change. These stories underscore the devastating consequences of the opioid crisis and the urgent need for prevention, treatment, and accountability.

Notable Quotes:

• “Fentinyl. Take a pin. Put a little tiny little tiny piece of fentinol in the top of that pin and that can kill five people. Put a little bit more, it can kill the entire town.” – Illustrates the extreme potency of fentanyl.
• “I blame big pharma. They put that Oxycottton out there and lied about it saying that it wasn't addictive.” – Highlights the perceived culpability of pharmaceutical companies.
• “If anyone could explain me the difference between Mackenzie Big Pharma Opi Cartel and the organizations of people like Pablo Escobar, I'm all ears.” – Raises a provocative question about the ethical equivalence of corporate actions and drug trafficking.
• “We failed to recognize the broader context of what was going on in society around us.” – McKenzie representative’s attempt to address their role in the crisis.

Conclusion:

The documentary presents a damning indictment of Purdue Pharma, the Sackler family, and the systemic failures that allowed the opioid crisis to unfold. It reveals a deliberate and calculated effort to prioritize profit over patient safety, fueled by aggressive marketing tactics, regulatory capture, and a lack of accountability. The crisis has evolved from prescription opioids to the deadly threat of fentanyl, leaving a trail of devastation in its wake. The documentary serves as a cautionary tale about the dangers of unchecked corporate power and the importance of ethical conduct in the pharmaceutical industry. It emphasizes the need for continued vigilance, stricter regulations, and a commitment to supporting those affected by addiction.